• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

熊去氧胆酸对胆固醇结石患者禁食和进食期间胆汁脂质偶联及胆固醇吸收的影响。

Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones.

作者信息

Lanzini A, Northfield T C

机构信息

Department of Medicine, St. George's Hospital Medical School, London, United Kingdom.

出版信息

Gastroenterology. 1988 Aug;95(2):408-16. doi: 10.1016/0016-5085(88)90498-2.

DOI:10.1016/0016-5085(88)90498-2
PMID:3391368
Abstract

The aim of this study was to determine the effect of chronic ursodeoxycholic acid administration on coupling of bile acids with cholesterol and phospholipid in hepatic bile, and on cholesterol absorption in the duodenum. A range of bile acid secretion rates was obtained during an evening meal and an overnight fast. Duodenal perfusion of polyethylene glycol as a nonabsorbable recovery marker and of [3H]cholesterol and [14C]lecithin as absorbable recovery markers was combined with continuous intravenous infusion of indocyanine green as a hepatic bile marker. Six subjects with gallstones were studied before and during chronic administration of ursodeoxycholic acid (675 mg/day). Duplicate pretreatment studies revealed good reproducibility for biliary lipid coupling and cholesterol absorption. During ursodeoxycholic acid administration there was a significant alteration not only in bile acid/cholesterol coupling (p less than 0.001), but also in bile acid/phospholipid coupling (p less than 0.001). Mean cholesterol absorption decreased from 25% to 15% (p less than 0.001) during ursodeoxycholic acid administration. These effects of chronic ursodeoxycholic acid administration on biliary lipid coupling are similar to those reported for acute administration, and are thus consistent with an effect caused by bile acid lipid-solubilizing capacity.

摘要

本研究的目的是确定长期给予熊去氧胆酸对肝胆汁中胆汁酸与胆固醇及磷脂结合的影响,以及对十二指肠胆固醇吸收的影响。在晚餐期间和夜间禁食期间获得了一系列胆汁酸分泌率。十二指肠灌注聚乙二醇作为不可吸收的回收标记物,灌注[3H]胆固醇和[14C]卵磷脂作为可吸收的回收标记物,并与连续静脉输注吲哚菁绿作为肝胆汁标记物相结合。对6名胆结石患者在长期给予熊去氧胆酸(675毫克/天)之前和期间进行了研究。重复的预处理研究表明,胆汁脂质结合和胆固醇吸收具有良好的可重复性。在给予熊去氧胆酸期间,不仅胆汁酸/胆固醇结合有显著改变(p小于0.001),而且胆汁酸/磷脂结合也有显著改变(p小于0.001)。在给予熊去氧胆酸期间,平均胆固醇吸收从25%降至15%(p小于0.001)。长期给予熊去氧胆酸对胆汁脂质结合的这些影响与急性给药时报道的影响相似,因此与胆汁酸脂质溶解能力引起的效应一致。

相似文献

1
Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones.熊去氧胆酸对胆固醇结石患者禁食和进食期间胆汁脂质偶联及胆固醇吸收的影响。
Gastroenterology. 1988 Aug;95(2):408-16. doi: 10.1016/0016-5085(88)90498-2.
2
Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.胆结石患者的肝脏胆汁脂质分泌及胆囊胆汁脂质含量:熊去氧胆酸的作用
Gut. 1990 Feb;31(2):226-30. doi: 10.1136/gut.31.2.226.
3
Effect of litholytic bile acids on cholesterol absorption in gallstone patients.溶石胆汁酸对胆结石患者胆固醇吸收的影响。
Gastroenterology. 1983 Feb;84(2):265-71.
4
Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.熊去氧胆酸对胆结石患者胆汁胆汁酸及胆汁脂质成分的影响。
Hepatology. 1984 Jan-Feb;4(1):107-11. doi: 10.1002/hep.1840040119.
5
Maintenance of hepatic bile acid secretion rate during overnight fasting by bedtime bile acid administration.睡前给予胆汁酸可在夜间禁食期间维持肝脏胆汁酸分泌率。
Gastroenterology. 1988 Oct;95(4):1029-35. doi: 10.1016/0016-5085(88)90179-5.
6
Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.熊去氧胆酸治疗胆固醇结石病:对肝脏3-羟基-3-甲基戊二酰辅酶A还原酶活性、胆汁脂质成分及血浆脂质水平的影响。
J Lipid Res. 1983 Apr;24(4):461-8.
7
Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.肥胖患者中鹅去氧胆酸和熊去氧胆酸的比较评估。体重维持和减轻期间对胆汁脂质代谢的影响。
Gastroenterology. 1991 Aug;101(2):490-6. doi: 10.1016/0016-5085(91)90029-k.
8
Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.鹅去氧胆酸和熊去氧胆酸对胆结石患者胆汁脂质分泌及胆汁酸合成影响的差异。
Gastroenterology. 1984 Jul;87(1):136-43.
9
Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.熊去氧胆酸和鹅去氧胆酸对胆固醇及胆汁酸代谢的影响。
Gastroenterology. 1986 Oct;91(4):1007-18. doi: 10.1016/0016-5085(86)90708-0.
10
Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid.
J Lipid Res. 1978 Aug;19(6):723-8.

引用本文的文献

1
Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.肝细胞激活转录因子 3 通过调节高密度脂蛋白和胆汁酸代谢来保护动脉粥样硬化。
Nat Metab. 2021 Jan;3(1):59-74. doi: 10.1038/s42255-020-00331-1. Epub 2021 Jan 18.
2
Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.长期服用辛伐他汀作为熊去氧胆酸辅助治疗的效果:对人体胆汁胆汁酸组成有协同作用,但对血清脂质无协同作用的证据。
Gut. 1999 Apr;44(4):552-6. doi: 10.1136/gut.44.4.552.
3
Pharmacological treatment of gallstones. Practical guidelines.
胆结石的药物治疗。实用指南。
Drugs. 1994 Mar;47(3):458-70. doi: 10.2165/00003495-199447030-00006.
4
Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.胆结石患者的肝脏胆汁脂质分泌及胆囊胆汁脂质含量:熊去氧胆酸的作用
Gut. 1990 Feb;31(2):226-30. doi: 10.1136/gut.31.2.226.
5
Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.通过SeHCAT试验测定熊去氧胆酸治疗对人体回肠胆汁酸吸收的影响。
Gut. 1991 Sep;32(9):1044-8. doi: 10.1136/gut.32.9.1044.